Phosphorylation of glycogen synthase kinase-3 beta at serine 9 confers cisplatin resistance in ovarian cancer cells.
about
Clinicopathological and biological significance of aberrant activation of glycogen synthase kinase-3 in ovarian cancerComparison of Intracellular Stress Response of NCI-H526 Small Cell Lung Cancer (SCLC) Cells to Platinum(II) Cisplatin and Platinum(IV) Oxoplatin.Glycogen synthase kinase 3β inhibitors induce apoptosis in ovarian cancer cells and inhibit in-vivo tumor growthDKK1 is a potential novel mediator of cisplatin-refractoriness in non-small cell lung cancer cell linesERK/GSK3β/Snail signaling mediates radiation-induced alveolar epithelial-to-mesenchymal transition.Lithium Chloride Promotes Apoptosis in Human Leukemia NB4 Cells by Inhibiting Glycogen Synthase Kinase-3 Beta.The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma.β-Catenin signaling pathway regulates cisplatin resistance in lung adenocarcinoma cells by upregulating Bcl-xl.Local anesthetic bupivacaine induced ovarian and prostate cancer apoptotic cell death and underlying mechanisms in vitro.Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy.Interaction between ERK and GSK3beta mediates basic fibroblast growth factor-induced apoptosis in SK-N-MC neuroblastoma cells.Alterations of phosphoproteins in NCI-H526 small cell lung cancer cells involved in cytotoxicity of cisplatin and titanocene Y.In vitro and in vivo anti-tumor and anti-inflammatory capabilities of the novel GSK3 and CKD9 inhibitor ABC1183.Progesterone Receptor Membrane Component 1 suppresses the p53 and Wnt/β-catenin pathways to promote human pluripotent stem cell self-renewal.FIBP knockdown attenuates growth and enhances chemotherapy in colorectal cancer via regulating GSK3β-related pathways
P2860
Q33831250-99492F98-CCA1-4869-9F66-F483553E2D12Q34309915-652680E3-4B7A-48E8-B010-87D22746D2B7Q35281886-3984E6D9-6829-478C-90EC-7C40C8F278E8Q35768464-FC835A66-020A-4E6F-B5EC-0FF55FDBC3C4Q35783218-C0335472-51F9-4470-B31C-F6D0D6284C2AQ36189756-64964676-0048-4BBA-A00A-D255BF34BCAAQ36540519-22C5C2C2-9C76-41DE-B6E3-946D08BCBAA3Q36624036-635C123E-D36E-44C2-B3F1-3C70F4E35062Q36915767-BEB7755F-016C-4DF5-97CD-0A985A9AD8FAQ37163149-022F8F6E-FFF0-4D52-9827-E446C418A3E6Q39260362-5B9BDE3E-DDE3-4F30-A1AE-E519FE767DAEQ39270001-A9AD9FE4-5B5C-41DD-83A4-641E31A09EC0Q50056226-86A1665F-8432-4F95-8F39-5C3DC48A975AQ50303613-E49013EC-63BD-4512-91E8-7D4647B8B296Q57049171-862E8FEE-445F-49A0-BE3B-0E00118994DB
P2860
Phosphorylation of glycogen synthase kinase-3 beta at serine 9 confers cisplatin resistance in ovarian cancer cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Phosphorylation of glycogen sy ...... tance in ovarian cancer cells.
@en
type
label
Phosphorylation of glycogen sy ...... tance in ovarian cancer cells.
@en
prefLabel
Phosphorylation of glycogen sy ...... tance in ovarian cancer cells.
@en
P2093
P1476
Phosphorylation of glycogen sy ...... stance in ovarian cancer cells
@en
P2093
P304
P50
P577
2007-09-01T00:00:00Z